Literature DB >> 11132977

Prediction of functional disability, recurrences, and chronicity after 1 year in 180 patients who required sick leave for acute low-back pain.

T Seferlis1, G Németh, A M Carlsson.   

Abstract

The aim of the study was to identify factors that predict low-back pain outcome at 12 months and thus to identify patients at risk for poor long-term outcomes. One hundred-eighty patients, all disabled by acute low-back pain, were included. Outcome (dependent) variables were Oswestry disability score, recurrences during the study year, and chronicity defined as 90 or more days off work for low-back pain during the study year, or a disease-specific sick-leave rate (a variable created by the authors) of more than 25%. Stepwise logistic regression analysis was performed. Thirty-three percent of the patients had an Oswestry score greater than 25, indicating moderate disability at the 1-year follow-up evaluation. Pain on coughing at study entry predicted a high likelihood of disability at 1 year, with a threefold risk. Many work days missed as a result of low-back pain in the past 2 years and lack of stimulating work tasks predicted recurrences during the year. A high Oswestry score assessed at study entry was the only factor that predicted chronicity. The factors revealed in the current study should help the clinician to identify patients at risk. The authors propose that the revealed predictors should be investigated extensively at the patient's first visit for acute low-back pain.

Entities:  

Mesh:

Year:  2000        PMID: 11132977     DOI: 10.1097/00002517-200012000-00002

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN: 0895-0385


  9 in total

Review 1.  Low back pain investigations and prognosis: a review.

Authors:  K M Refshauge; C G Maher
Journal:  Br J Sports Med       Date:  2006-06       Impact factor: 13.800

2.  Employer, insurance, and health system response to long-term sick leave in the public sector: policy implications.

Authors:  Bodil Heijbel; Malin Josephson; Irene Jensen; Eva Vingård
Journal:  J Occup Rehabil       Date:  2005-06

3.  The value of physical performance tests for predicting therapy outcome in patients with subacute low back pain: a prospective cohort study.

Authors:  Babak Moradi; Julia Benedetti; Anita Zahlten-Hinguranage; Marcus Schiltenwolf; Eva Neubauer
Journal:  Eur Spine J       Date:  2009-04-11       Impact factor: 3.134

Review 4.  Acute low back pain: systematic review of its prognosis.

Authors:  Liset H M Pengel; Robert D Herbert; Chris G Maher; Kathryn M Refshauge
Journal:  BMJ       Date:  2003-08-09

5.  Clinical examination findings as prognostic factors in low back pain: a systematic review of the literature.

Authors:  Lisbeth Hartvigsen; Alice Kongsted; Lise Hestbaek
Journal:  Chiropr Man Therap       Date:  2015-03-23

6.  What is the association between the presence of comorbidities and the appropriateness of care for low back pain? A population-based medical record review study.

Authors:  Shanthi Ramanathan; Peter Hibbert; Louise Wiles; Christopher G Maher; William Runciman
Journal:  BMC Musculoskelet Disord       Date:  2018-11-06       Impact factor: 2.362

7.  Risk factors for sickness absence due to low back pain and prognostic factors for return to work in a cohort of shipyard workers.

Authors:  Evangelos C Alexopoulos; Eleni C Konstantinou; Giorgos Bakoyannis; Dimitra Tanagra; Alex Burdorf
Journal:  Eur Spine J       Date:  2008-07-23       Impact factor: 3.134

8.  Frequency and interrelations of risk factors for chronic low back pain in a primary care setting.

Authors:  Marie-Martine Lefevre-Colau; Fouad Fayad; François Rannou; Jacques Fermanian; Fernand Coriat; Yann Mace; Michel Revel; Serge Poiraudeau
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

9.  Spinal mechanical load: a predictor of persistent low back pain? A prospective cohort study.

Authors:  Eric W P Bakker; Arianne P Verhagen; Cees Lucas; Hans J C M F Koning; Bart W Koes
Journal:  Eur Spine J       Date:  2007-04-12       Impact factor: 3.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.